EVANS GARY C

Track

Insider profile

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 98% 68% 82%
Transactions
20 80% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
EVANS GARY C's trades of United States Antimony Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
205.65
Quantity 11,616
Value US$4,816,506
Transaction date
Purchase
Price
468.73
Quantity 81,817 +15.1%
Value US$1,398,481
Transaction date
Purchase
Price
64.57
Quantity 84,847 -48.9%
Value US$1,084,012
Transaction date
Purchase
Price
0.45
Quantity 21,068 +2.3%
Value US$9,481
Transaction date
Purchase
Price
0.45
Quantity 31,369 +3.5%
Value US$14,116
Transaction date
Purchase
Price
0.45
Quantity 20,944 +2.4%
Value US$9,425
Transaction date
Purchase
Price
0.45
Quantity 5,137 +0.6%
Value US$2,312
Transaction date
Purchase
Price
0.45
Quantity 147,994 +20.7%
Value US$66,597
Transaction date
Purchase
Price
0.45
Quantity 119,201 +16.6%
Value US$53,640
Transaction date
Purchase
Price
0.45
Quantity 68,990 +10.7%
Value US$31,046
Transaction date
Purchase
Price
0.45
Quantity 238,212 +58.3%
Value US$107,195
Transaction date
Purchase
Price
0.45
Quantity 13,999 +1.6%
Value US$6,300
Transaction date
Purchase
Price
0.42
Quantity 65,902 +19.2%
Value US$27,679
Transaction date
Purchase
Price
0.41
Quantity 51,653 +17.7%
Value US$21,178
Transaction date
Purchase
Price
0.40
Quantity 251,281 +628.2%
Value US$100,512
Transaction date
Purchase
Price
0.38
Quantity 40,000 +inf%
Value US$15,200
US Novavax Inc (NVAX)
Transaction date
Sale
Price
146.50
Quantity 625 -100.0%
Value US$91,562
US Novavax Inc (NVAX)
Transaction date
Sale
Price
212.00
Quantity 14,768 -47.8%
Value US$3,130,816
US Novavax Inc (NVAX)
Transaction date
Sale
Price
210.00
Quantity 9,732 -24.0%
Value US$2,043,720
US Novavax Inc (NVAX)
Transaction date
Sale
Price
150.44
Quantity 10,500 -3.2%
Value US$1,579,620
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-25 2026-03-25
PrS Proposed sale
11,616
205.65
US$4,816,506 		11,616 205.65 US$4,816,506
2025-09-30 2025-09-26
B Purchase
81,817 +15.1%
468.73
US$1,398,481 		81,817 +15.1% 468.73 US$1,398,481
2024-12-11 2024-12-10
B Purchase
84,847 -48.9%
64.57
US$1,084,012 		84,847 -48.9% 64.57 US$1,084,012
2023-01-20 2023-01-19
B Purchase
21,068 +2.3%
0.45
US$9,481 		21,068 +2.3% 0.45 US$9,481
2023-01-20 2023-01-18
B Purchase
300 +0.0%
0.45
US$135 		300 +0.0% 0.45 US$135
2023-01-17 2023-01-13
B Purchase
31,369 +3.5%
0.45
US$14,116 		31,369 +3.5% 0.45 US$14,116
2023-01-17 2023-01-12
B Purchase
20,944 +2.4%
0.45
US$9,425 		20,944 +2.4% 0.45 US$9,425
2023-01-17 2023-01-11
B Purchase
5,137 +0.6%
0.45
US$2,312 		5,137 +0.6% 0.45 US$2,312
2022-12-21 2022-12-16
B Purchase
147,994 +20.7%
0.45
US$66,597 		147,994 +20.7% 0.45 US$66,597
2022-12-16 2022-12-15
B Purchase
119,201 +16.6%
0.45
US$53,640 		119,201 +16.6% 0.45 US$53,640
2022-12-15 2022-12-14
B Purchase
68,990 +10.7%
0.45
US$31,046 		68,990 +10.7% 0.45 US$31,046
2022-12-15 2022-12-13
B Purchase
238,212 +58.3%
0.45
US$107,195 		238,212 +58.3% 0.45 US$107,195
2022-12-21 2022-12-10
B Purchase
13,999 +1.6%
0.45
US$6,300 		13,999 +1.6% 0.45 US$6,300
2022-12-12 2022-12-09
B Purchase
65,902 +19.2%
0.42
US$27,679 		65,902 +19.2% 0.42 US$27,679
2022-12-12 2022-12-08
B Purchase
51,653 +17.7%
0.41
US$21,178 		51,653 +17.7% 0.41 US$21,178
2022-12-12 2022-12-07
B Purchase
251,281 +628.2%
0.40
US$100,512 		251,281 +628.2% 0.40 US$100,512
2022-12-09 2022-12-06
B Purchase
40,000 +inf%
0.38
US$15,200 		40,000 +inf% 0.38 US$15,200
2021-06-03 2021-06-01
US Novavax Inc (NVAX)
S Sale
625 -100.0%
146.50
US$91,562 		625 -100.0% 146.50 US$91,562
2021-03-17 2021-03-15
US Novavax Inc (NVAX)
S Sale
14,768 -47.8%
212.00
US$3,130,816 		14,768 -47.8% 212.00 US$3,130,816
2021-03-17 2021-03-15
US Novavax Inc (NVAX)
S Sale
9,732 -24.0%
210.00
US$2,043,720 		9,732 -24.0% 210.00 US$2,043,720
2020-08-20 2020-08-18
US Novavax Inc (NVAX)
S Sale
10,500 -3.2%
150.44
US$1,579,620 		10,500 -3.2% 150.44 US$1,579,620